tiprankstipranks
Advertisement
Advertisement

McKesson Secures New $5 Billion Revolving Credit Facility

Story Highlights
  • On April 24, 2026, McKesson replaced two existing credit lines with a new $5 billion revolving facility maturing in 2031.
  • The new facility increases multicurrency capacity, adds a leverage covenant excluding MMS, and bolsters McKesson’s long-term liquidity and deal flexibility.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
McKesson Secures New $5 Billion Revolving Credit Facility

Claim 55% Off TipRanks

McKesson ( (MCK) ) has provided an update.

On April 24, 2026, McKesson entered into a new $5.0 billion senior unsecured revolving credit facility maturing in April 2031, replacing its prior $1.0 billion 364-day facility and $4.0 billion five-year facility, both of which had no outstanding borrowings at termination. The new agreement expands multicurrency borrowing capacity to a $4.5 billion sublimit, maintains largely similar terms to the prior structure, and introduces a total debt-to-Consolidated EBITDA covenant capped at 4.25x, with a temporary step-up to 4.75x after sizable cash acquisitions, excluding debt and EBITDA from its Medical-Surgical Solutions segment, thereby enhancing McKesson’s long-term liquidity and financial flexibility for future strategic activity.

The most recent analyst rating on (MCK) stock is a Buy with a $828.00 price target. To see the full list of analyst forecasts on McKesson stock, see the MCK Stock Forecast page.

Spark’s Take on MCK Stock

According to Spark, TipRanks’ AI Analyst, MCK is a Neutral.

The score is driven primarily by strong cash generation and solid operating performance, reinforced by a constructive earnings call with raised FY2026 guidance and continued capital returns. Offsetting these positives are balance-sheet leverage/volatility and weaker near-term technical momentum, with valuation appearing only average given the P/E and very low dividend yield.

To see Spark’s full report on MCK stock, click here.

More about McKesson

McKesson Corporation is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and related solutions to providers, pharmacies and health systems. The company operates across multiple geographies and currencies, requiring large, flexible credit facilities to support its working capital, acquisitions and broader capital management strategy.

Average Trading Volume: 808,325

Technical Sentiment Signal: Buy

Current Market Cap: $101.4B

For an in-depth examination of MCK stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1